Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

Journal of the American College of Cardiology

Volumn 33, Issue 3, 1999, Pages 654-660

  Ito, Hiroshi ^a   Taniyama, Yoshiaki ^a   Iwakura, Katsuomi ^a   Nishikawa, Nagahiro ^a   Masuyama, Tohru ^b   Kuzuya, Tsunehiko ^b   Hori, Masatsugu ^b   Higashino, Yorihiko ^a   Fujii, Kenshi ^a   Minamino, Takazo ^a  

^a Sakurabashi Watanabe Hospital   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; NICORANDIL; SIGMAT; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NA(+)-K(+)-EXCHANGING ATPASE; NICORANDIL; POTASSIUM CHANNELS; PROGNOSIS; RADIONUCLIDE VENTRICULOGRAPHY; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 0033101517     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00604-4     Document Type: Article

References (33)

1. Hillis LD, Former S, Braunwald E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990;16:313-5.
2. Gruppo Italiano per lo Studio Della Streptokinesi Nell' Infarcto Micardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-401.
3. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983;309:1477-82.
4. Sakata Y, Kodama K, Momamura K, et al. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J 1997;133:616-21.
5. Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients wtih acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-9.
6. Mahaffey KW, Puma JA, Barbagelata A, et al. Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial. Circulation 1997;96 Suppl I:I-206.
7. Auchampach JA, Cavero I, Gross GJ. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent pottasium channels. J Cardiovasc Pharmacol 1992;20:765-71.
8. Mizunuma T, Nithipatikom K, Gross GJ. Effects of nicorandil and glyveryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995;29:482-9.
9. Klein HH, Pich S, Lindert-Heimberg S, Shade-Brittinger C, Maisch B, Nebendahl K. Comparative study on the effects of intracoronary nicorandil and nitroglycerin in ischaemic, reperfused porcine hearts. Eur Heart J 1995;16:603-9.
10. Galie N, Guarnieri C, Ussia GP, et al. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol 1995;26:477-84.
11. + channels. Am J Physiol 1996;270:H1744-56.
12. Cheesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I: A comparison between intravenous plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 1987;76:142-54.
13. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
14. Ito H, Iwakura K, Oh H, et al. Recovery of coronary microcirculation after coronary reflow in patients with anterior wall acute myocardial infarction: its correlates to myocardial viability. Circulation 1995;91:656-62.
15. Ito H, Tomooka T, Sakai N, et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation 1993;87:355-62.
16. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo H-W. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305.
17. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986;74:469-76.
18. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
19. Kloner RA, Ganote CE, Jennings RB. The "no reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
20. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 1980;62:945-52.
21. Johnson WB, Malone SA, Pantely G A, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation 1988;78:462-72.
22. Erlebacher JA, Weiss JL, Weisfeldt ML, Bulkley MB. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute ventricular enlargement. J Am Coll Cardiol 1984;4:201-8.
23. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987;75:299-306.
24. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72.
25. Villaneuva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implication in determining extent of myocardial salvage. Circulation 1993;88:2596-606.
26. Ambrosio G, Weisman HF, Mnnisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989;80:1841-61.
27. Jeremy RW, Links JM, Becker CC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol 1990;16:695-704.
28. Pieper GM, Gross GJ. Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 1992;2:225-32.
29. Stahl LD, Aversano TR, Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation 1986;74:843-51.
30. Akai K, Wang Y, Sato K, et al. Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol 1995;26:541-7.
31. Yao Z, Gross GJ. Effects of KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89:1769-75.
32. Rohmann S, Weygandt H, Chelling P, et al. Effect of bimakalim, an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall motion, and oxygen consumption in swine. Cardiovasc Res 1994;28:858-63.
33. Mizumura T, Nithipatikom K, Gross GJ. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effect of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995;92:1236-45.